IPP Bureau
Axithra appoints Lars Kongsbak as CEO ahead of clinical validation and Series A fundraise
By IPP Bureau - May 04, 2026
Precision medicine company advances Raman spectroscopy-based therapeutic drug monitoring platform for rapid, patient-specific dosing solutions
C-CAMP launches NBEC 2026 with up to Rs 20 Crore in prizes and investment opportunities
By IPP Bureau - May 04, 2026
India’s largest life sciences entrepreneurship competition opens applications for startups, innovators and student teams nationwide
KIMS Hospitals launches Institute of Advanced Neurosciences in Bengaluru
By IPP Bureau - May 04, 2026
New Centre of Excellence at Electronic City campus to offer specialised care in epilepsy, cerebrovascular disorders, neurointervention, skull base and spine surgery
India unveils first-ever national framework to tackle childhood diabetes
By IPP Bureau - May 04, 2026
New policy aims to standardise screening, diagnosis and lifelong care for children with diabetes across India’s public health system
Fertin Pharma appoints Aditya Sharma as Managing Director for India operations
By IPP Bureau - May 04, 2026
Healthcare and consumer wellness leader brings extensive experience in business transformation, commercial strategy and growth leadership to Fertin India
Karunanithi Ponnusamy elevated to President – Animal Health Business at Alembic Pharma
By IPP Bureau - May 04, 2026
With over 30 years of pharmaceutical industry experience, Ponnusamy will lead Alembic’s animal health business strategy, market expansion, and operational growth initiatives
Zydus Lifesciences acquires France-based FBC Medical through subsidiary Amplitude SAS
By IPP Bureau - May 04, 2026
Acquisition of medical equipment distributor aims to strengthen European commercial operations and optimise distribution costs
Alkem Laboratories receives 7 observations following US FDA inspection at Daman facility
By IPP Bureau - May 04, 2026
The US regulator conducted an inspection at the Amaliya manufacturing plant between April 20 and May 1, 2026
Aurobindo arm CuraTeQ receives Health Canada approval for bevacizumab biosimilar Bevqolva
By IPP Bureau - May 04, 2026
Notice of Compliance from Health Canada enables marketing authorisation for cancer biosimilar in Canadian market
Gufic Biosciences deepens global oncology push with fresh investment in Australia’s Selvax
By IPP Bureau - May 04, 2026
Selvax, founded in 1987, is focused on developing novel immunotherapy solutions with applications in both human and veterinary oncology
Moderna posts Q1 2026 loss despite revenue surge
By IPP Bureau - May 04, 2026
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
KIMS Hospitals launches Advanced Neurosciences Institute in Bengaluru
By IPP Bureau - May 04, 2026
The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof
Sanofi India appoints Rahul Bhatnagar as Chairman of Board of Directors
By IPP Bureau - May 03, 2026
Rahul Bhatnagar succeeds Aditya Narayan, who completed a decade-long distinguished tenure
FDA grants breakthrough status to Laguna's mRNA blood test for schizophrenia diagnosis
By IPP Bureau - May 02, 2026
The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay
FDA renews IQOS “reduced-risk” status backing PMI’s smoke-free strategy in regulatory win
By IPP Bureau - May 02, 2026
The renewal covers two versions of the IQOS device and three HEETS tobacco variants
